Epidermal Growth Factor Tyrosine Kinase Inhibitor Therapy Inferior to Second-Line Chemotherapy in EGFR Wild-Type Non-Small Cell Lung Cancer Patients: Results of French Nationwide Observational Study

Translational Lung Cancer Research - Hong Kong
doi 10.21037/tlcr.2017.10.16
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

AME Publishing Company


Related search